Article
EGFR Mutations and PD-L1 Expression in Early-Stage Non-Small Cell Lung Cancer: A Real-World Data From a Single Center in Brazil.
The oncologist - 3 Nov 2022
Alves Pinto Icaro, de Oliveira Cavagna Rodrigo, Virginio da Silva Aline Larissa, Dias Josiane Mourão, Santana Iara Vidigal, Souza Laísa Caroline, Ferreira da Silva Flávio Augusto, Biazotto Fernandes Maria Fernanda, Junqueira Pinto Gustavo Dix, Negreiros Izabella Santos, Santiago Gonçalves Maria Fernanda, de Paula Flávia Escremim, Berardinelli Gustavo Nóriz, Casagrande Giovanna Maria Stanfoca, Oliveira da Silva Marcela, Albino da Silva Eduardo Caetano, de Oliveira Marco Antonio, Jacinto Alexandre Arthur, Duval da Silva Vinicius, Reis Rui Manuel, De Marchi Pedro, Leal Letícia Ferro
Abstract excerpt
BACKGROUND: Targeted and immunotherapies are currently moving toward early-stage settings for patients with non-small cell lung cancer (NSCLC). Predictive biomarkers data are scarce in this scenario. We aimed to describe the frequency of EGFR mutations and PD-L1 expression levels in early-stage non-squamous patients with NSCLC from a large, single Brazilian oncology center. METHODS: We retrospectively evaluated...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.